Nundina › Kalender entdecken › FDA-Zulassungen neuer Arzneimittel-Kalender › FDA approves Degevma (denosumab-adet)FDA approves Degevma (denosumab-adet)25. September 2026The FDA approved Degevma (denosumab-adet), a biologic from Teva Pharmaceuticals, Inc.. Form: Injectable, Subcutaneous. Application BLA761481.FDA-Zulassungen neuer Arzneimittel-KalenderMehr aus diesem Kalender